Nearly two thousand people living with undiagnosed HIV have been identified thanks to a pioneering NHS initiative that tests adults for the virus in emergency departments across England. Launched in April 2022, this ground-breaking programme has been quietly making a significant impact on public health.
New figures reveal that 1,900 previously unknown HIV infections have been discovered since the scheme began. Experts believe that opt-out testing is allowing people who might not have been tested otherwise to receive a diagnosis. Research by the UK Health Security Agency (UKHSA) suggests that almost all (93%) of those diagnosed had no record of a prior HIV test, indicating that the initiative is effectively identifying hidden cases.
The implications for patients are substantial. Those who test positive for HIV, hepatitis B, or hepatitis C are offered immediate specialist support and tailored treatment plans. Early diagnosis is crucial for managing these conditions, improving long-term health outcomes, and preventing onward transmission. A recent economic evaluation published in The Lancet HIV estimated that the initial 802 new HIV diagnoses from the programme's early phase could prevent approximately 187 HIV-related deaths and 28 new transmissions over the next two decades.
NHS national medical director Professor Francesca Swords highlights the importance of knowing one's HIV status, comparing it to checking blood pressure. She notes how the programme is diagnosing individuals before symptoms appear, allowing them to access crucial treatment and reduce the risk of unknowingly transmitting the virus. This approach aligns with the NHS's commitment to early detection of HIV and other blood-borne viruses, making every patient contact an opportunity for improved health outcomes.
The programme forms a key part of the government's HIV Action Plan 2025-2030, a collaborative effort by the Department of Health and Social Care (DHSC), UKHSA, and NHS England. This ambitious plan aims to eliminate new HIV transmissions within England by 2030. £156 million will be invested from April 2026 to March 2029 to expand and sustain opt-out testing in emergency departments across very high and high HIV prevalence areas.